Your browser doesn't support javascript.
loading
Changes in blood viscosity with synthetic protease inhibitors.
Hitosugi, Masahito; Niwa, Munehiro; Takahashi, Tomoyoshi; Kurosu, Akira; Nihei, Hirohisa; Nagai, Toshiaki; Tokudome, Shogo.
Afiliação
  • Hitosugi M; Department of Legal Medicine, Dokkyo University School of Medicine, Tochigi 321-0293, Japan. hitosugi@dokkyomed.ac.jp
J Pharmacol Sci ; 91(4): 334-6, 2003 Apr.
Article em En | MEDLINE | ID: mdl-12719663
ABSTRACT
We examined the effects on whole blood viscosity and coagulation time of various dosages of the synthetic low-molecular protease inhibitors gabexate mesilate and nafamostat mesilate with an oscillation-type viscometer. When either agent was added, blood viscosity decreased dose-dependently along a sigmoid-like curve. Furthermore, coagulation time was shorter with gabexate mesilate than with nafamostat mesilate owing to the differences of half-life in human blood. Thrombin generation, which results from the activation of coagulation factors, is inhibited by synthetic protease inhibitors and subsequently decreases blood viscosity dose-dependently.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Viscosidade Sanguínea Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Viscosidade Sanguínea Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2003 Tipo de documento: Article